Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Omega-N-Methylarginine

Research Papers that Mention the Interaction

We have previously demonstrated that CFR to adenosine was significantly increased after systemic infusion of L-NMMA in normal volunteers but not in recently transplanted denervated hearts.
American journal of physiology. Heart and circulatory physiology  •  2007  |  View Paper
In a separate series of experiments, MBF during adenosine was reduced in the presence of l-NMMA (p < 0.05 analysis of variance).
This was most apparent at the low dose of adenosine, where MBF response to adenosine was blunted in the presence of l-NMMA (2.08 +/- 1.34 ml/min/g vs. 1.48 +/- 1.32 ml/min/g, placebo vs. l-NMMA, p < 0.05).
Journal of the American College of Cardiology  •  2002  |  View Paper
The addition of the NO synthase competitive inhibitor, NG-monomethyl-L-arginine (NMMA), or the adenosine receptor antagonist, theophylline, prevented the increase in NO production by adenosine.
The American journal of physiology  •  1995  |  View Paper
Furthermore, infusion of NG-monomethyl-L-arginine (L-NMMA) blunted vasodilator responses to Ado infusion only in Ado responders (P < 0.01 vs. post-L-NMMA) and had no effect on exercise in either group.
Journal of applied physiology  •  2006  |  View Paper
adenosine flow … ( L-NMMA ) requires inhibition of CNS neuronal nitric oxide synthase (nNOS), increased cardiac sympathetic nerve stimulation, and β2-agonism of coronary arterioles because (1) heart … raise arterial pressure to levels equivalent to those given L-NMMA plus adenosine also did not show increased myocardial blood flow (MBF).
Circulation  •  2005  |  View Paper
RBF during combined infusion of L-NMMA and adenosine was not different from that during adenosine alone, but the decrease in renal vascular resistance was less pronounced during this combination.
Journal of hypertension  •  2005  |  View Paper
L-NMMA blunted the effect of adenosine on cGMP both in unstimulated samples and in aggregated platelets without any effect on cAMP synthesis.
Thrombosis research  •  2002  |  View Paper
Adenosine increased coronary blood flow before and after L-NMMA (+399.5 +/- 27.5% and +511.9 +/- 33.3%, respectively).
Journal of the American College of Cardiology  •  1996  |  View Paper
Before infusion of L-NMMA, adenosine caused a dose-dependent increase in FBF from 2.3 to 15.9 mL.min-1.dL-1.
During concurrent infusion of L-NMMA, adenosine increased FBF from 1.7 to 10.0 mL.min-1.dL-1, and this change from baseline was significantly reduced compared with that before L-NMMA (P < .05).
L-NMMA also attenuated the FBF response to adenosine when the basal constrictor effect of L-NMMA was prevented by coinfusion of the NO donor sodium nitroprusside (n = 6, P < .01).
Circulation  •  1995  |  View Paper
Adenosine applied via pressurized micropipettes directly onto the wall or at a distance of 25 µm from the wall of first-order … diameter = 54 ± 1 µm) elicited dose-dependent dilations of 15–46% that were significantly reduced by the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, …–4M).
Journal of Vascular Research  •  2001  |  View Paper
Show More